Clinical Trial Update: A Study of Enhancing Response to MK-3475 in Advanced Colorectal Cancer [Phase 1]

View source ↗

Summary

A Phase 1 study of pembrolizumab (MK-3475) for advanced colorectal cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• MK-3475 (pembrolizumab) (pembrolizumab)

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Conditions: Colorectal Cancer | Phase 1 | Status: COMPLETED